1-15 of 173

Breaking Silos With STAMP! Detecting Cardiorenal Risk and Integrating Nonsteroidal MRA Therapy in Patients With HF and CKD
CME/CEBreaking Silos With STAMP! Detecting Cardiorenal Risk and Integrating Nonsteroidal MRA Therapy in Patients With HF and CKD

Translating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD
CME/CETranslating Nonsteroidal MRA Evidence Into Practice: Optimizing Cardiorenal Outcomes in Patients With CKD

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs

A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
CME/CEA Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition

Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
- advertisement

Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
MinuteCE®Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load

From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
MinuteCE®From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection

The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
MinuteCE®The Binder Selection Playbook: Matching the Right Strategy to the Right Patient

The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
MinuteCE®The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
- advertisement

Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
MinuteCE®Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal

Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
MinuteCE®Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN












































